Author

Liqiang Qi

Institution: Chinese Academy of Medical Sciences & Peking Union Medical College

Observed institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Tianjin Medical University

ORCID: 0009-0008-4170-9573

Observed ORCID: 0009-0008-4170-9573

OpenAlex ID: A5059340986

Identification of TUBB2A as a Cancer-Immunity Cycle-Related Therapeutic Target in Triple-Negative Breast Cancer

2023 · Jia Li, Jingchun Yao, et al. · Molecular Biotechnology · 7

HER2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the histone modification related genes

2023 · Jia Li, Jingchun Yao, et al. · Scientific Reports · 3

The efficacy and safety of apatinib combined with paclitaxel and carboplatin dose-dense regimen in neoadjuvant therapy for locally advanced triple-negative breast cancer.

2022 · Qiao Li, Jiaxuan Liu, et al. · Journal of Clinical Oncology · 1

Clinicopathologic characteristics and prognosis of breast neuroendocrine carcinoma: An analysis of 32 cases

2012 · Yinchun Zhang, Liqiang Qi, et al. · Clinical Oncology and Cancer Research

Works count: 4

Citation count: 11

H-index: 2

I10-index: